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A B S T R A C T
Background: Autophagy is an intracellular hemostasis mechanism, responding to extracellular or intracellular
stresses. Sulfur mustard (SM) induces cellular stress. Iranian soldiers exposed to SM gas, during the Iraq-Iran war,
suffer from delayed complications even 30 years after exposure. In this study, for exploring the SM effect on
autophagy pathway, gene and protein expression of autophagy markers are evaluated in the lung of SM-exposed
people.
Methods: 52 FFPE lung tissues of SM-exposed people and 33 lung paraffin blocks of non-exposed patients to SM
were selected. LC3 and Beclin-1 mRNA expressions were evaluated by QRT-PCR. LC3-B protein and LC3II/LC3I
proteins ratio were detected by Immunohistochemistry and immunoblotting method. The collected data were
analyzed in SPSS, and P value≤ 0.05 was considered significant.
Results: LC3 gene expression in SM-exposed subjects (median CT value= 4.97) increased about 4 fold compared
with the control group (median CT value= 0.46, P= 0.025). Beclin-1 mRNA expression had not significant
difference between two groups. After adjusting the confounding variables such as drug usage, LC3-B protein
(P= 0.041) and LC3II/LC3I ratio (P= 0.044) were found significantly lower in the lung cells of SM-exposed
group.
Conclusion: Upon exposure to SM gas, the lung cells are affected by acute cellular stress such as oxidative stress.
The study results show that LC3 mRNA level increases in these patients, but, surprisingly, LC3-B protein via
unknown mechanism has been down-regulated. N-acetyl cysteine and salbutamol drugs could induce the au-
tophagy, and help to reduce the SM effects and improve the clinical condition of SM-injured patients.
1. Introduction
Macroautophagy (here after autophagy) is induced in response to
various stimuli, including endogenous and exogenous stresses, such as
amino acid or growth factor deprivation, endoplasmic reticulum stress,
mitochondrial damage, pathogen infection and in response to various
immune stimuli [1–6]. From yeast to mammalian cells, one way to
eliminate cellular stress is degradation of damaged cytoplasmic
molecules and organelles by autophagosome-lysosomes (autolysosome)
that is known as autophagy pathway [7–9].
> 30 genes have been known for the regulation of autophagy in
yeasts, 16 similar genes are found in humans [10–12]. Many mechan-
isms regulate autophagy machinery such as the mammalian target of
rapamycin (mTOR) that down-regulates it, while PI3K hVPS34 induces
it [13–16]. Beclin-1 (acting like Atg6 gene in the yeast) contributes to III
phosphatidylinositol 3-kinase complex for autophagy stating and
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autophagosome formation. Also, microtubule-associated light chain 3
(LC3 in mammals, same as ATG8 of yeast) plays a part in the fusion step
of autophagosome to lysosome and formation of autolysosome. LC3 has
three isoforms in mammalian tissues (LC3A, LC3B, and LC3C) and
shows two forms: a soluble form called LC3 I (molecular weight,
18 kDa) and a lipidated form called LC3 II (molecular weight, 16 kDa)
[17,18]. Autophagy stimulator converts LC3-I to LC3-II. Therefore,
phosphatidylethanolamine (PE)-conjugated form of LC3 (LC3-II) is
correlated to autophagosome formation, and the ratio of LC3-II/LC3-I is
an indicator of autophagy process [19–21].
The autophagy and immune system have close and mutual relations.
Some immune-related signaling molecules could regulate autophagy
such as pathogen-recognition receptor (PAMPs and DAMPs), IFN-γ,
tumor necrosis factor-α (TNF-α), and many other cytokines [1,22]. In
the human atherosclerotic vascular disease, it was shown that TNF-α in
the smooth cells could up-regulate LC3 and Beclin-1 genes expression
[23]. However, stimulation of autophagy by TNF-α is cell dependent.
The evidence shows that autophagy regulates TNF-α secretion by
macrophages and dendritic cells [1]. Also, it has been confirmed that
Interleukin (IL)-1α and IL-1β induce autophagy in human macro-
phages. On the other hand, disruption of normal autophagy pathway
has been involved in increased secretion of the pro-inflammatory cy-
tokines such as IL-1α, IL-1β, and IL-18 [1]. Altogether, the interaction
of autophagy and the immune system is complicated and tightly de-
pends on the trigger of autophagy and the type of organs which the
autophagy induced.
The role of autophagy in the pathogenesis of lung diseases is dual
and dubious [24]. The degradation of mitochondria by autophagy
mechanism worsens the pathogenesis of the chronic obstructive pul-
monary disease (COPD) by activating cell death programs [25]. Well,
Zhi-Hua Chen and collagenous reported that the ratio of LC3B-II/LC3B-I
and the expression of some essential proteins of the autophagy pathway
significantly increased in COPD lung [26]. However, in pulmonary
hypertension, autophagy may have a protective effect by modulating
cell proliferation and death. In other disorders, autophagy may con-
tribute to the pathogenesis of idiopathic pulmonary fibrosis and cystic
fibrosis [25].
Sulfur mustard (SM) is known as an alkylating agent. In the acute
phase of exposure, it could cause mild conjunctivitis in the eye and
sneezing and cough in the pulmonary system [27]. In the delayed phase
of SM exposure, the victims may suffer from blindness or obstruction of
upper airways, chronic bronchitis, and bronchiolitis in the lung [28].
This chemical weapon was used several times by the Iraq army against
Iranian civilians and soldiers in the Iraq-Iran war (1980–1988), re-
sulting in>45,000 victims of delayed complications of SM [29].
Although many studies have been conducted on the effects of SM
gas, the molecular mechanism of SM effects at the cellular level is still
unclear, especially in the delayed phase. Therefore, there is no ther-
apeutic clinical approach to lung injuries caused by SM [30]. Studies
indicate that the victims suffer from pulmonary complications, com-
monly chronic obstructive pulmonary disease, [31] and obliterate
bronchiolitis [32].
Based on what was discussed, autophagy has a critical role in re-
sponse to cellular stress. Thus, we designed the current study to eval-
uate the essential markers of autophagy such as mRNA and protein
expression of LC3 and Beclin-1 in formalin-fixed paraffin-embedded
(FFPE) lung tissues of SM-injured patients and compared them with
FFPE lung tissues of patients non-exposed to SM.
2. Materials and Methods
2.1. Ethics Statement
The ethical issue of our study was approved by the Research Ethics
Committee of Shahed University (41/198215) and Medical Faculty of
Tarbiat Modares University (52/1547).
2.2. Tissue specimens
The lung paraffin blocks were provided by the pathology depart-
ment of general hospitals in Tehran City, Iran (2005–2011). They were
used as samples. The inclusion and exclusion criteria were described in
our previous study [33], briefly, having documented exposure to sulfur
mustard and chronic respiratory complication were important inclusion
criteria for SM-exposed group and control group was chosen when their
lung biopsies have normal area and not exposure history to mustard or
other toxic gas. The age and addiction conditions of samples in the
exposed and control group were matched. Table 1 presents the detailed
characteristics of the samples.
2.3. Total RNA extraction and quantitative real-time reverse transcription-
PCR
RNA extraction process from FFPE tissue has been explained in our
previous study [34]. Briefly, high quality and quantity total RNA was
extracted by modification in the manufacturer’s protocol of RNeasy
FFPE Kit (Qiagen- Germany). The Agilent RNA integrity number (RIN)
show the quality of this extracted RNA, but this value is not sensitive for
degraded RNA in FFPE samples. The mean RNA fragment size de-
termines RNA quality in FFPE tissues [35]. The percentage of RNA
fragments> 200 nucleotides was calculated (Macrogen, Korea) as the
indicator of the quality of RNA, DV200 metric, and DV200>30% were
accepted.
The high purity extracted RNA (280/260 ratio above 1.9) was
transcribed to cDNA by high capacity cDNA reverse transcription kit
(ABI-USA). The primers of β-actin and phosphoglycerate kinase 1
(PGK1) as two reference genes and LC3 and Beclin-1 as target genes
Table 1





0 F 6 F
Age (year) 44.65 ± 10.19 47.78 ± 15.73
Smoking 10 (19.2%) 9(27.2%)
Pathology Diagnosis
Respiratory bronchiolitis 5 1
Constrictive bronchiolitis 26 1
Chronic bronchiolitis 15 1
Bronchiectasis 2 0
Anthracosis 1 2
Benign tumor 1 1
Malignant-tumor 0 14
Bulla 0 3
Interstitial lung disease 0 4
Idiopathic pulmonary fibrosis 0 2
Pulmonary congestion 1 0




Spontaneous pneumothorax 0 3
Drug Usage
Fluticasone 23 (44.23%) 1 (3.03%)
Salbutamol 7 (13.46%) 6 (18.18%)
N-Acetyl cysteine 12 (23.07%) 2 (6.06%)
Atrovent 1 (1.9%) 2 (6.06%)
Prednisolone 5 (9.61%) 3 (9.09%)




*The Severity of pulmonary involvement in the exposed group were classified
by clinical symptoms such as lung sounds and spirometry documents, according
to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [63].
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were designed manually with amplicon length< 125 bp and exon-exon
junction manner to detect mRNA expression of the studied genes. The
amplification efficiency of each primer was calculated using the slope of
the regression line in the standard curve by ABI StepOne 2.3 software
(ABI-USA). The standard curve of each gene was drowned using a serial
dilution of the PCR product of the same genes. Table 2 presents the
sequence of primers.
We used Gene Runner 5.0.1 and online oligo calculator software to
estimate thermodynamic state and secondary structure of the primers
[36]. The primers were produced commercially (TAG Copenhagen-
Denmark). The RT-qPCR was performed with SYBR Green I dye on the
Applied Biosystems StepOnePlus™ Real-Time PCR System with a
holding stage at 95 °C for 15min and amplifying stages of 1) 95 °C for
30 s and 2) 60 °C for 60 s (40 cycles). All assays were done three times.
The Pfaffl equation was used to analyze the relative quantification of
RT-qPCR [37].
2.4. Immunohistochemistry
The lung paraffin blocks of samples were supplied from the pa-
thology department of tertiary hospitals. After cutting 3-µm sections
from each sample, the immunohistochemistry standard protocol was
carried out on samples [38]. After deparaffinization and rehydration,
antigen retrieval step was done with heat and pressure created by au-
toclave (Prestige, England) in Tris-EDTA epitope retrieval buffer (pH 9).
Endogenous peroxidase blocking was done by 3% H2O2 in methanol;
protein blocker serum-free solution (Dako- Denmark) was used for
protein blocking. Anti-human LC3 (NanoTools- USA, clone 5F10, 1:50)
was used for detection of LC3. The Envision Detection System (Dako-
Denmark) was used as detection kit. After hematoxylin counterstaining,
the slides were mounted. For LC3, human normal kidney section was
used as the positive control. For negative control slides, the primary
antibody was not used.
Co-author pathologist (blinded to sample data) evaluated staining
under a light microscope. The number of cytoplasmic and nucleus
LC3+ puncta/cell was counted, too. The slides were assessed according
to intensity and amount. The intensity of staining was scored as follows:
negative (0); weak (1); moderate (2); strong (3). The percentage of LC3
positive cells was graded into five categories: 0 (≤5%), 1 (6–25%), 2
(26–50%), 3 (51–75%) and 4 (> 75%). Quantity and quality of LC3
stained cells were calculated by multiplying the intensity score at the
percentage of positive cells. Throughout each slide, 10 randomly
chosen oil immersion field were evaluated at ×1000 for LC3 by
Labomed light microscope (LX500, USA).
2.5. Protein extraction and immunoblotting
Protein extraction from FFPE tissue was derived from Kawashima
et al. described method [39], with a little modification. Four 10-µm
FFPE sections were cut and de-paraffinized with 1.5mL xylene (twice)
and rehydrated with a serial dilution of ethanol. The pellets were re-
suspended in extraction buffer (300mM Tris-HCl, sodium dodecyl sul-
fate [SDS] 2%, 0.5M 2-mercaptoethanol) and homogenized by homo-
genizer stirrer (WiseStir- Mexico) for 15 s with high power. After that,
they were incubated at 90 °C for 90min. At the final step, after 14,000g
centrifugation for 20min at 4 °C, the supernatant solution would have
the extracted protein. The soluble protein was precipitated by acetone
method [40]. The obtained protein pellet was re-suspended in re-
suspension buffer (1.5M Tris base, 20% Glycerol, 0.002M SDS, 0.06M
urea). The protein concentration was measured by 2-D Quant kit (GE-
USA).
The extracted protein was stained with Coomassie Brilliant Blue R
250 (Merk-Germany), and 100 μg of each total protein sample was
loaded to each well of SDS-PAGE 20%. Electrophoresis was done by
BioRad Mini-PROTEAN II system with a standard protocol [41]. After
that, the separated protein was transferred onto PVDF (Polyvinylidene
Fluoride, BioRad, USA) membrane by BioRad Criterion Blotter. The
transferring time was 90min, 30mA. After blocking of the membrane
with 2% BSA (Bovine Serum Albumin, Sigma, Germany), the membrane
exposed to anti-LC3 antibody (1:300, NanoTool-USA) and anti-α-Tu-
bulin antibody (1:800, Sigma, Germany) overnight at 4 °C with low
shaking. The anti-mouse IgG (1:7000, Sigma, Germany) conjugated
with horseradish peroxidase (HRP) was applied as the secondary anti-
body. For visualization of the protein bands, ECL detection kit (Kardan,
Iran) was used. The bands appeared on X-ray film were analyzed by
Image J software (Wayne Rasband [retired from NIH]) and the LC3-I,
LC3-II proteins were normalized to α-Tubulin. In the end, the ratio of
LC3-II/LC3-I was determined for each sample.
2.6. Statistical analysis
Statistical analyses were performed in SPSS 22 (SPSS Inc., Chicago
Ill). The normality of data was evaluated by the Kolmogorov-Smirnov
test. The difference between the control and exposed groups was con-
sidered significant at P≤0.05.
For real-time PCR test, the cycle threshold (CT) value was de-
termined by ABI StepOne 2.3 software (ABI-USA) and median, and
standard deviation (SD) were computed. The Spearman correlation was
used for determination of correlation among gene expression or protein
expression and clinical documents (for example, forced expiratory
value in one score [FEV1], forced vital capacity [FVC], etc.). The cor-
relation between gene or protein expression with the clinical symptom,
pathological finding, and drug usage were done by Mann-Whitney test.
The comparing between severity of pulmonary complications with
Beclin1 and LC3 genes expression were estimated by the Kruskal-Wallis
test. The comparison of LC3B between two groups was done with the
Mann-Whitney test. Adjustment of this test for extracting the con-
founding variable -drug-using- effect were done with two way ANOVA.
At the first step, LC3B transformed to rank. Then in two way ANOVA,
the rank of LC3B was considered as the dependent variable, study group
and using medicine as the independents.
3. Results
3.1. The concentration and quality of the extracted mRNA
After extraction of mRNA from FFPE tissues, their concentration
was measured with NanoDrop 2000. The samples discarded when OD
260/280 ratio was<1.8. The mean ± SD of mRNA concentration for
the exposed and control groups were 292.8 ± 140.24 ng/µL and
322.52 ± 298.8 ng/µL, respectively. The DV 200 metric analysis
showed that the %fragmented RNA < 200 bp was 51.7 ± 3.66% for
Table 2
The sequence of the primers.
Gene Forward (3 > 5) Reverse (5 > 3) Amplicon length (bp) Efficiency (%) GenBank, accession number
Actin CGTCTTCCCCTCCATCGTG GGTGAGGATGCCTCTCTTGCTC 111 95.29 NM_001101.3
PGK GGCATACCTGCTGGCTGGATG ACAGGACCATTCCACACAATCTGC 104 96.06 NM_000291.3
LC3 CGAACAAAGAGTAGAAGATGTCCGAC GCTGCTTCTCACCCTTGTATCG 92 98.47 NM_022818.4
BECN1 CAGCCAGGATGATGTCCACAG CCCAGTGACCTTCAGTCTTCG 107 92.88 NM_003766.3
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the exposed group, and 50.95 ± 10.76% for the control group. The
samples with DV200 > 30% were chosen for further studies.
3.2. The different effect of SM gas on LC3 and Beclin-1 genes expression
RT-qPCR evaluated LC3 and Beclin-1 genes expression. Fig. 1 shows
the median value of LC3 expression as 4.97 in the exposed group and
0.46 in the control group. The Mann-Whitney analysis shows this dif-
ference was significant (P= 0.025). But Beclin-1 expression showed no
significant difference between the two groups. Median values of Beclin-
1 were 1.85 and 1.43 in the exposed and control groups, respectively
(P= 0.323). Fig. 1 shows the mRNA expression of these two genes.
There was not any significant correlation between LC3 and Beclin-1
gene expression in control and SM exposed patients group. Moreover, in
the exposed group, Beclin-1 and FEV1/FVC ratio had a direct correla-
tion (r= 0.714, P=0.047). Also, no correlations were found between
the expression of these two genes and the clinical signs and symptoms
such as cough, sputum, and dyspnea as well as with pathological
findings.
3.3. The SM gas down-regulate the LC3-B protein in immunohistochemistry
test
For detection and localization of LC3-B in lung samples, we used
specific antibody for this protein. Distribution of brown patches in-
dicates LC3-B localization in the lung cells. We calculated the presence
of positive cells and intensity of LC3-B protein expression in each
sample. The results demonstrated that the median value of the LC3-B
protein was 25 in the exposed lung and 62.5 in the control group. This
difference was non-significant (P= 0.164). Fig. 2 shows the LC3-B
Immunohistochemistry test.
Some of the exposed and control patients used salbutamol, flutica-
sone, N-acetyl cysteine, and prednisolone (Table 1). When we deleted
the effect of some influencers such as “drug use” in both group, the
results changed, and the difference between LC3-B protein of the SM-
exposed and control group got significant (P=0.041). In the exposed
group, among the above drugs, salbutamol and N-acetyl cysteine had
the most substantial effect. The results show that LC3-B protein ex-
pression was 25 in non-consumers of salbutamol and 125 in the drug
consumers in the exposed group (P=0.017). Salbutamol increased
LC3-B protein in the lung of people exposed to SM. Also, the same result
obtained when N-acetyl cysteine studied; 0 and 100 LC3-B protein va-
lues were observed in non-consumers and consumers of NAC in the
exposed lung, respectively (P= 0.034). In the control group, we did not
obtain this finding, and these two drugs did not affect LC3 protein ex-
pression at the lung of the control group (P=0.8).
In the lung of SM exposed individuals, LC3 protein had a direct
correlation with chronic bronchitis pathology (P=0.029). Also, this
protein was associated with malignancy diagnosis (Squamous-cell
carcinoma (SCC) in the control group (P=0.05).
3.4. The SM gas reduce LC3-II/LC3-I in western blotting test
After protein extraction from FFPE lung tissues, 100 µg was used for
the detection of LC3 mount and determination of LC3-II/LC3-I ratio.
The α-tubulin protein was consider as normalized control. The LC3-I,
LC3-II and α-tubulin immune blot bands were quantified by Image-j
software. After normalization with α-tubulin, median values of LC3-I,
LC3-II, and LC3-II/LC3-I in the control group were 0.80, 0.31, and 0.52,
respectively. These parameters for the SM exposed group were 0.70,
0.18, and 0.16, respectively. The statistical analysis shows that these
differences were not significant (P=0.533, P=0.423, and P=0.238,
respectively). Fig. 3 shows the immunoblot of LC3 protein.
LC3-II protein and LC3-II/LC3-I ratio had inverse correlation with
FEV1 spirometry parameter (r=−0.828, P= 0.000; r=−0.751,
P= 0.001, respectively) in the exposed group. Also, the LC3-II/LC3-I
ratio was higher in the exposed group who had chronic bronchitis pa-
thology (P=0.02). In the control group, LC3-II protein in malignancy
cases was higher than that in the other pathologic conditions
(P= 0.05).
4. Discussion
SM causes many complications in different organs include chronic
bronchitis and pulmonary fibrosis in the respiratory system [43]; hy-
perpigmentation, dry skin and multiple cherryangiomas in the skin [44]
and bulbar conjunctiva and limbal tissue abnormalities in the eyes [45].
Lung and pulmonary system are the major organs affected by the SM
agent. Lung involvement extends from acute to chronic (long term and
delayed phase) [46]. Many studies have been conducted in animal
models and on human samples for determination of the delayed me-
chanism of SM gas many years after exposure. Emad and colleagues
have shown an inflammation state in the lung of SM-exposed patients.
They analyzed the cytokines such as IL-8, IL-1β, IL-6, TNF-α, IL-12,
TGF-β, insulin-like growth factor-1, and epidermal growth factor in
bronchoalveolar lavage fluids. They reported that these cytokines and
chemokines were higher in SM-exposed patients with pulmonary fi-
brosis ratio compared to the healthy controls [47]. They also mentioned
that IL-8, IL-1β, IL-6, TNF-α, IL-12 cytokines in the patients with
bronchiectasis caused by SM gas were higher than that in people non-
exposed to SM [48]. But other studies reject this hypothesis. Yaraee and
colleagues reported the serum level of TNF, IL-1α, IL-1β, and IL-1Ra
cytokines were significantly lower in the exposed group after 20 years
than those in the controls [49]. Also, our previous study on FFPE lung
samples of SM-exposed patients showed that mRNA expression of
proinflammatory cytokines such as IL-1β, TNF-α and TNF-α receptor in
the lung of SM-exposed people had no difference with non-SM-exposed
patients with other pulmonary diseases [42]. Therefore, the
Fig. 1. The mRNA expression of mi-
crotubule-associated light chain 3 (LC3)
(A), Beclin-1 (B) in lung tissue of SM-
exposed and control subjects. RT-qPCR
valued mRNA expression of 85 samples
(52 SM-exposed and 33 control). The
expression of LC3 is upregulated in SM-
exposed lung while Beclin-1 showed no
significant difference between the SM-
exposed and control groups.
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inflammation could not be the main reason for the observed compli-
cations in the pulmonary system of SM-exposed people many years after
the exposure. Some research has shown that autophagy pathway has a
protective effect in infectious, autoimmune, and inflammatory diseases
[22], and autophagy regulates production and secretion of in-
flammatory cytokines and can inhibit inflammation initiation [1]. In
the COPD disease have shown autophagy was inhibited in their mac-
rophages that contribute to the excessive inflammatory response in
airway [50].
On the other hand, Malaviya et al. reported that 6 h after the ex-
posure of rats with SM gas, the LC3 expression transitionally increased
in the rats’ lungs. This expression was not observed 24 h after exposure,
Fig. 2. Protein expression of LC3-B (A) detected by an antibody against this antigen in lung section in the exposed and control groups. LC3-B protein in the exposed
lung non-significantly decreased. B and C show LC3-B positive cells in the control group lung and D and E show the distribution of LC3-B positive cell in SM-exposed
lung. LC3-positive puncta are clear in D and E. F and G show positive control for LC3 molecule, human normal kidney tissue.
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and there were no differences between LC3 expression of the exposed
and non-exposed rats with SM gas [51]. Thus, SM gas exposure could
induce autophagy in lung cells, and autophagy could regulate in-
flammation cascade.
Another inducer of autophagy pathway is oxidative stress and for-
mation of intracellular reactive oxygen species [7]. Taravati et al. re-
ported that antioxidant paraoxonase 1 activity decreased significantly
in veterans who exposed to SM 20–25 years ago [52]. Also, Shohrati
et al. reported serum level of glutathione in patients with a history of
exposure to a single high dose of SM gas decreased and mal-
ondialdehyde activities in these patients increased compared to healthy
nonsmoking individuals with no history of exposure to SM [53]. An-
other role of autophagy is the clearance of apoptotic cell to prevent
inflammation or reduction of inflammation in efferocytosis mechanism
[54]. Mosayebzadeh et al. compared apoptotic features and caspase-3
expression in FFPE lung of the SM-exposed people and control subjects
and reported apoptotic cells were significantly higher in the lungs of the
SM-exposed group>20 years after exposure [55]. All above documents
consider that autophagy pathway should occur for resolving many
different stresses in the SM-exposed lung cells.
The present study shows that the mRNA level of LC3 molecule from
the autophagy pathway in SM-exposed lungs significantly increased
more than four-fold compared with that in the control group. But LC3
protein decreased in these samples. We infer that the lung cells are
trying to increase autophagosome formation for reduction of SM gas
stress, but an unknown mechanism reduces LC3 protein expression and
inhibits the beneficial intracellular clearance. This agent regulates au-
tophagy at the protein level and may inhibit autophagosome vacuole
formation or reduce the half-life of LC3-B protein. The determination of
this inhibitory mechanism needs further molecular studies. Also, we
found that some drugs such as N-acetyl cysteine (NAC) and salbutamol
would affect LC3 protein expression, and this protein increased in SM-
exposed patients who had received these drugs. Pajonk and colleagues
reported NAC could inhibit 26S proteasome function which blocked
radiation induced NF-KB and affect on following genes expression [56].
Also the reduction of glutathione could active mammalian target of
rapamycin (mTOR) and cause oxidative stress in cells. So, supple-
mentation of NAC, as a precursor of glutathione, replenishes in-
tracellular glutathione and inhibits the mTOR signaling and then in-
duces autophagy. Afterward, autophagy could reduce oxidative stress
and inhibit damages to the cells [57]. The improvement of symptoms
and clinical conditions of SM-exposed patients which consume NAC
compared to the placebo group [58] may be due to this effect of NAC.
Also, salbutamol as β2 adrenergic receptor agonist is known as an in-
ducer of autophagy [59]; however, the mechanism of salbutamol action
in the autophagy pathway has not been determined. Hence, NAC and
salbutamol drugs attempt to recover the distorted condition of SM-ex-
posed lung cells via increasing LC3 protein of the autophagy pathway.
In our study, LC3 mRNA was high, but an expression of Beclin-1
mRNA, another gene in the autophagy pathway, has not changed. Some
studies show that autophagy has not a unique pathway and when
Beclin-1 gene is knocked out by small interfering RNA (siRNA), LC3-
associated phagocytosis (LAP) of Burkholderia pseudomallei in murine
macrophage (RAW 264.7) cells is observed after rapamycin treatment
but not after starvation condition. Therefore, autophagy is independent
of Beclin-1 in rapamycin induction [60]. This finding confirms the
observed rapamycin dependent autophagy pathway in SM-exposed
people. The cells under stress condition select the best way for survival
and resolve the stressor. Our result may be due to the use of an alter-
native pathway of autophagy in lung cells exposed to SM. Also, Adib-
zadeh et al. reported that the serum level of Vitamin D3 in the exposed
people to SM diminished compared to non-exposed individuals [61]. As
Vitamin D3 is an inducer of autophagy [62], administration of this vi-
tamin along with NAC may synergistically induce autophagy.
This study was designed on archived FFPE lung of patients and
obtaining the match sample to defined criteria was very problematic,
also usage of less than human biological sample is an important ethical
issue. So, we designed at least tests for detection of autophagy and we
could not carry out additional tests on these samples such as IHC of P62
protein or prepare transmission electron microscopy (TEM) images.
Finally, we suggest that further studies should investigate the lung
cells (type I or II pneumocytes, alveolar macrophage, etc.), which go
through autophagy. This result helps us to determine the precise mo-
lecular mechanism of long-term and delayed effects of SM gas and is
beneficial for decision making about the clinical approach for SM-in-
jured people.
5. Conclusion
The evidence suggests that autophagy pathway should be stimu-
lated for reduction of cellular stress in lung tissue of SM-exposed
people. Thus, the therapeutic approaches that support autophagy
clearance mechanism are useful for SM-injured people.
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